CRYZ
Quinone oxidoreductase
Also known as: QOR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q08257
- Gene
- CRYZ
- Ensembl
- ENSG00000116791
- Chromosome
- 1
- Canonical length
- 329 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. The former class is also called phylogenetically-restricted crystallins. This gene encodes a taxon-specific crystallin protein which has NADPH-dependent quinone reductase activity distinct from other known quinone reductases. It lacks alcohol dehydrogenase activity although by similarity it is considered a member of the zinc-containing alcohol dehydrogenase family. Unlike other mammalian species, in humans, lens expression is low. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. One pseudogene is known to exist. [provided by RefSeq, Sep 2008]
Canonical amino-acid sequenceUniProt
329 residues, UniProt reviewed canonical sequence.
>Q08257|CRYZ
1 MATGQKLMRA VRVFEFGGPE VLKLRSDIAV PIPKDHQVLI KVHACGVNPV ETYIRSGTYS
61 RKPLLPYTPG SDVAGVIEAV GDNASAFKKG DRVFTSSTIS GGYAEYALAA DHTVYKLPEK
121 LDFKQGAAIG IPYFTAYRAL IHSACVKAGE SVLVHGASGG VGLAACQIAR AYGLKILGTA
181 GTEEGQKIVL QNGAHEVFNH REVNYIDKIK KYVGEKGIDI IIEMLANVNL SKDLSLLSHG
241 GRVIVVGSRG TIEINPRDTM AKESSIIGVT LFSSTKEEFQ QYAAALQAGM EIGWLKPVIG
301 SQYPLEKVAE AHENIIHGSG ATGKMILLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRYZ can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 309 nTPM
Expression across tissuesHPA
Tissue
- kidney: 309 nTPM
- liver: 264 nTPM
- epididymis: 114 nTPM
- choroid plexus: 88 nTPM
- gallbladder: 65 nTPM
- pancreas: 59 nTPM
Single-cell type
- oocytes: 263 nCPM
- hepatocytes: 261 nCPM
- epididymal efferent duct ciliated cells: 131 nCPM
- epididymal efferent duct absorptive cells: 118 nCPM
- epididymal principal cells: 106 nCPM
- fallopian tube ciliated cells: 103 nCPM
Immune cell
- T-reg: 43 nTPM
- memory B-cell: 33 nTPM
- gdT-cell: 32 nTPM
- memory CD4 T-cell: 32 nTPM
- NK-cell: 30 nTPM
- memory CD8 T-cell: 30 nTPM
Brain region
- choroid plexus: 94 nTPM
- midbrain: 33 nTPM
- white matter: 32 nTPM
- pons: 32 nTPM
- thalamus: 31 nTPM
- hypothalamus: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- identical protein binding
- mRNA 3'-UTR binding
- NADPH binding
- quinone reductase (NADPH) activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Quinone oxidoreductase/zeta-crystallin, conserved site
- GroES-like superfamily
- Alcohol dehydrogenase-like, C-terminal
- Alcohol dehydrogenase-like, N-terminal
- Enoylreductase domain
- NAD(P)-binding domain superfamily
- Zinc-binding dehydrogenase
- Alcohol dehydrogenase GroES-like domain
- Zinc-Containing ADH Family: Quinone Oxidoreductase/CCCR
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRYZ as an antibody target. Whether an autoantibody or antibody against CRYZ could matter depends on whether native CRYZ is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRYZ is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRYZ as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...